Vyv
PrivateLast Round
Series A
Dec 1, 2020
Total Funding Raised
$5.5M
Company Overview
Vyv operates in Frontier & Industrial Tech and is based in Latham, New York. Its latest recorded funding round was a Series A round in December 2020.
Vyv is a health-tech company that manufactures and sells antimicrobial LED lights designed to kill germs, bacteria, and viruses.
Sector
Frontier & Industrial Tech
Verticals
Medical Devices, Smart Buildings, Facility Management, Consumer Electronics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vyv Comparables
Compare Vyv with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nextsense | 81% | |
| illumiPure | 81% | |
| Current Lighting Solutions | 80% |
For institutional investors. Book with your work email.
Vyv Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 1, 2020 | ||||
| Debt | Nov 1, 2019 | ||||
| Seed | Jan 25, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vyv Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalyst by Wellstar | Series A |
| Plum Alley Investments | Seed |
| Healthcare Association of New York State | Series A |
| Belle Capital | Seed |
| New York Ventures | Seed |
| Connectivity Ventures Fund | Seed |
| Tamiami Angel Funds | Debt, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 61% to 2.9K.
- Feb 26, 2025
Grew 43% QoQ, from 107 to 153 employees.
For institutional investors. Book with your work email.
Vyv Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vyv's valuation, stock price, and market status.
Is Vyv a public or private company?
Vyv is a private company.
What is the current stock price of Vyv?
Vyv is a private company, so its shares have no public market price. Caplight tracks Vyv's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vyv worth (valuation)?
Valuation information for Vyv is not publicly available.
Can I buy Vyv stock?
Vyv shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vyv's last funding round?
Vyv's most recent funding round was Series A on December 1, 2020.
Who are the main investors in Vyv?
Key investors in Vyv include Catalyst by Wellstar, Plum Alley Investments, Healthcare Association of New York State, Belle Capital, New York Ventures.
Will Vyv IPO soon?
No public IPO plans have been announced for Vyv.
How can I track Vyv secondary market activity?
Caplight tracks bids, offers, and trades in Vyv's shares on secondary markets.